Cargando…

The chemotherapy source book /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Perry, Michael C. (Michael Clinton), 1945-
Formato: Libro
Idioma:Inglés
Publicado: Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins, c2008.
Edición:4th ed.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Scientific basis of cancer chemotherapy
  • Norton-simon hypothesis
  • Drug resistance
  • Principles of chemotherapy
  • Clinical trials
  • Hematopoietic growth factors
  • Biologic response modifiers: principles of biotherapy
  • Intraventricular and intrathecal therapy
  • Intraperitoneal chemotherapy
  • Continuous intravenous infusion chemotherapy
  • Intraarterial chemotherapy
  • Isolated regional therapy
  • Hematopoietic stem cell transplantation
  • Oral toxicity
  • Dermatologic toxicity
  • Extravasation
  • Hypersensitivity reactions
  • Ocular side effects of chemotherapy
  • Cardiotoxicity of cancer therarpy
  • Pulmonary toxicity of antineoplastic therapy
  • Gastrointestinal complications of chemotherapy
  • Hepatotoxicity of chemotherapeutic agents
  • Renal and electrolyte abnormalities due to chemotherapy
  • Chemotherapy-induced peripheral neuropathy
  • Vascular toxicity of antineoplastic agents
  • Second malignancies after chemotherapy
  • Chemotherapy in pregnancy
  • Gonadal complications and teratogenicity of cancer therapy
  • Central venous access for chemotherapy
  • Systemic therapy for advanced melanoma
  • General issues in brain tumor chemotherapy
  • Chemotherapy of head and neck cancer
  • Chemotherapy of lung cancer
  • Breast cancer
  • Gastrointestinal cancer
  • Endocrine tumors
  • Chemotherapy of genitourinary cancers
  • Chemotherapy of gynecologic cancers
  • Chemotherapy of carcinoma of unknown primary site
  • Chemotherapy of bone and soft tissue sarcomas
  • Chemotherapy for pediatic solid tumors
  • Chemotherapy of hodgkin's lymphoma
  • Non-hodgkin's lymphoma
  • Acute myeloid leukemia, aucte lymphoblastic leukemia, and chronic lymphocytic leukemia
  • Chemotherapy of the myelodysplastic syndromes
  • Management of myeloproliferative disorders and chronic myeloid leukemia
  • Chemotherapy of multiple myeloma and other plasma cell disorders.